This article first appeared on GuruFocus .
Release Date: November 06, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Docebo Inc ( NASDAQ:DCBO ) reported strong Q3 2026 results with subscription revenue growth accelerating to 12.4% and full-year revenue growth guidance raised to 14%.
-
The company announced a $60 million special dividend, demonstrating confidence in its highly recurring business model and strong cash flow generation.
-
Docebo Inc ( NASDAQ:DCBO ) is making strategic investments in verticals like government and healthcare, with government pipeline building above expectations and a major healthcare medtech win in the quarter.
-
The launch of Knowledge and AI agents expands the addressable market by targeting CIOs and CROs, potentially increasing average revenue per user (ARPU) from $600,000 to higher levels.
-
The acquisition of 365 Talents is integrating well, with cross-selling momentum and product integration ahead of schedule, positioning Docebo Inc ( NASDAQ:DCBO ) for skills intelligence growth.
Negative Points
-
Q4 revenue guidance appears conservative, with minimal incremental revenue from Q4 bookings, partly due to FX headwinds and enterprise deals expected to close late in December.
-
Gross margin pressure is expected to continue into Q4 due to a higher mix of professional services, which is growing faster than subscription revenue.
-
Government deals slipped from Q3 to Q4 due to complex procurement processes, creating uncertainty around timing of revenue recognition.
-
The company faces potential sales cycle elongation as it targets new buyers like CIOs, though early signs are positive.
-
Docebo Inc ( NASDAQ:DCBO ) is still in early stages of its FDE (Forward Deployed Engineer) program and healthcare vertical, with monetization strategies yet to be fully validated.
Q & A Highlights
-
This Powerful Chart Made Peter Lynch 29% A Year For 13 Years
-
How to calculate the intrinsic value of a stock?
-
Is DCBO fairly valued? Test your thesis with our free DCF calculator.
Q: Can you unpack the Q4 guidance, which seems conservative given the confident tone and strong pipeline? A: CFO Brandon Farber explained that the Q4 guide starts from Q3 ARR, accounts for fewer days in Q4, and reflects a slight FX headwind from a stronger U.S. dollar in October. Because the Q4 pipeline is heavily enterprise-weighted, mature deals are expected to close in December, so the guide includes little to no incremental revenue from Q4 bookingsthose will impact 2027 guidance. He noted full-year revenue growth is now projected at 14%, up from the initial 10.6% guide, with subscription revenue growth accelerating each quarter (12% in Q1, 12% in Q2, 12.4% in Q3, 12.8% guided for Q4).
Q: What is the rationale behind the $60 million special dividend, and what does it mean for deleveraging and M&A capacity? A: CFO Brandon Farber said the dividend will be funded from remaining debt capacity, taking debt from $90 million to $150 million and leaving net debt of approximately $108 milliona net debt to EBITDA ratio of 1.9x. Capital allocation priorities remain consistent: invest back in the business (healthcare, FDE, government hiring) while maintaining ~20% EBITDA margins, remain opportunistic on M&A (two acquisitions in 2026) but focus on execution over the next 12 months, and return cash to shareholders. He noted $82 million was spent on buybacks in 2026, but a recent SIB saw only $2.5 million filled of a possible $70 million, making a special dividend the best use of excess capital and a signal of board confidence in the highly recurring, predictable cash flow.
Q: What is the current operational traction in the government vertical, and what is the outlook post the U.S. midterm elections? A: CEO Alessio Artufo said government was Docebo's first verticalization and the strategy is playing out, with a strong pipeline build above expectations in Q3. Significant deals expected in the quarter slipped due to complex SLED and federal procurement processes, but he has great confidence they will close this fiscal year. He emphasized the public sector strategy is diversified beyond federal, including state and local government and partners like Deloitte, and that the team is being staffed up to meet future goals.
Q: How is the launch of Knowledge expanding Docebo's reach into the broader enterprise, and how are you teeing up sales to CROs, CCOs, and the CIO office? A: CEO Alessio Artufo noted that more than 50% of customers already use Docebo for external use cases budgeted by the CRO and CCO offices, so the capability to sell beyond L&D buyers is already built in. With AI blending learning and knowledge, Docebo is now connecting to broader enterprise data sources like SharePoint, SalesSource, Confluence, Notion, and Google Drive. He expects the CIO office to become more involved and said Docebo will repeat the playbook it used when approaching new buyers years ago.
Q: What is the significance of having 600 beta customers for the new release? A: CEO Alessio Artufo explained the distinction between private and public beta, noting that public beta with 600 customers provides real practitioner feedback that closes the gap between what product and engineering teams anticipate and actual usage. He framed it as part of an engineering-first and customer-first mindset, with a monetization component: coming out of the gates prepared to welcome net new customers who have already gone deep in the product.
Q: What are you seeing competitively in the LMS refresh cycle, and is there an RFP tailwind from legacy incumbent disruption? A: CEO Alessio Artufo said Docebo focuses on itself rather than competitors, but modern complex enterprises want a platform with deep workflow, enterprise capabilities, security, governance, and certifications like FedRAMP. He sees little competition offering AI, learning, knowledge, and skills intelligence in a highly integrated platform that can withstand organizations of 30,000 to 100,000+ peoplea moat that is very hard to replicate.
Q: How is the cross-sell of the Skills Intelligence (365 Talents) platform into the existing base progressing, and how does AI content creation cross-pollinate? A: CEO Alessio Artufo said the acquisition closed earlier this year and the focus has been on integrating the products for a seamless experience, with the latest release recently shipped. Large enterprises are benefiting most from the combination, and Docebo is on track to surpass its budget expectations. On Creator, he said personalization is a key differentiator, and agents are being developed that understand learner profiles and create material in real time using Creator as the underlying enginethe first Creator agent has already shipped.
Q: Where are you on the FDE (forward-deployed engineer) investments, and what has customer interest been? A: CEO Alessio Artufo said the strategy of embedding FDEs in the largest enterprise accounts is unchanged, and the team is now fully staffed with target accounts identified. Over the next three to six months, Docebo will validate the operating model, customer engagement, monetization strategy, and the boundaries of FDE value creation on top of customer- and FDE-built agents. He noted customers are already raising their hands for help building no-code agents, and updates are expected over the next couple of quarters.
Q: What is driving gross margin pressure, and should we expect it to extend into Q4 and beyond? A: CFO Brandon Farber said subscription gross margins are essentially unchanged from historical levels; quarterly movements relate to specific professional services projects and PS growing faster than subscriptions. He expects a similar trend in Q4, but as Docebo laps a strong enterprise year in 2027, PS growth should become more consistent with subscription revenue, normalizing and allowing gross margins to tick back up.
Q: How should we think about EBITDA margin expansion into 2027 given reinvestments in healthcare and FDE? A: CFO Brandon Farber highlighted 34% EBITDA growth this quarter alongside top-line growth and said Docebo remains a disciplined capital investor. He expects R&D to stay roughly flat as a percentage of revenue into 2027, continued G&A leverage, and some EBITDA margin expansion, with full guidance coming in February.
Q: Did
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
